Moderna has finalized the design and dosage of its phase 3 COVID-19 vaccine trial, keeping it on track to start the pivotal test next month. Work to get the 30,000-subject phase 3 trial underway is ...
Chemomab Therapeutics has announced that it has successfully completed its End-of-Phase 2 meeting with the FDA, aligning on the design of a single Phase 3 trial for its lead product candidate, ...
Midjourney, the well-known AI art generation system and independent research lab, has announced the rollout of phase 1 of its new website design making it available on a beta subdomain for users to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results